They might be the next Genentech but theiir web site makes them sound like they’re trying to sell my town a monorail.
November 9, 2026 at 8:11 AM
They might be the next Genentech but theiir web site makes them sound like they’re trying to sell my town a monorail.
That was my first thought. You see Genentech parking stickers (iykyk) on so many cars in San Mateo County.
November 9, 2026 at 5:07 PM
That was my first thought. You see Genentech parking stickers (iykyk) on so many cars in San Mateo County.
There are examples of successes, of course, going all the way back to Genentech and through many other biotechs. But then there are the Calicos of the world.
November 9, 2026 at 8:55 AM
There are examples of successes, of course, going all the way back to Genentech and through many other biotechs. But then there are the Calicos of the world.
As I say above, maybe I am wrong. Maybe they're the next Genentech or Amgen or Gilead.
Time will tell.
Time will tell.
November 9, 2026 at 7:47 PM
As I say above, maybe I am wrong. Maybe they're the next Genentech or Amgen or Gilead.
Time will tell.
Time will tell.
November 7, 2026 at 4:31 PM
Hype from big pharma and biotech startups is very intense. I worked in drug discovery for decades as a medicinal chemist; I recall one spin out of Genentech proposing AI directed drug discovery back in the 1980s! Obviously that went nowhere fast. Big pharma companies are like sheep following hype.
"Vertex has used roughly 50 AI companies to comb through its data set of 10,000 drug compounds, Leiden said. Not one managed to generate a working drug."
"Executives leading the companies that discover new drugs say AI isn’t going to cure cancer anytime soon. They are dimming the hype around the technology’s use in drug research, saying human biology is too complicated even for superintelligence." www.wsj.com/tech/ai/sili...
November 8, 2026 at 7:12 PM
Hype from big pharma and biotech startups is very intense. I worked in drug discovery for decades as a medicinal chemist; I recall one spin out of Genentech proposing AI directed drug discovery back in the 1980s! Obviously that went nowhere fast. Big pharma companies are like sheep following hype.
Scientist 3, Lung Biology & Inflammation
Genentech - South San Francisco, US
Read the full job description and apply⤵️
jobrxiv.org/job/scientis...
#ScienceJobs
Genentech - South San Francisco, US
Read the full job description and apply⤵️
jobrxiv.org/job/scientis...
#ScienceJobs
November 7, 2026 at 4:31 PM
Scientist 3, Lung Biology & Inflammation
Genentech - South San Francisco, US
Read the full job description and apply⤵️
jobrxiv.org/job/scientis...
#ScienceJobs
Genentech - South San Francisco, US
Read the full job description and apply⤵️
jobrxiv.org/job/scientis...
#ScienceJobs
Postdoctoral Fellow - Multimodal Technologies & Complex Human Models, Regev and Chen Labs
Genentech - South San Francisco, US
jobrxiv.org/job/postdoct...
#ScienceJobs
Genentech - South San Francisco, US
jobrxiv.org/job/postdoct...
#ScienceJobs
November 7, 2026 at 4:31 PM
Postdoctoral Fellow - Multimodal Technologies & Complex Human Models, Regev and Chen Labs
Genentech - South San Francisco, US
jobrxiv.org/job/postdoct...
#ScienceJobs
Genentech - South San Francisco, US
jobrxiv.org/job/postdoct...
#ScienceJobs
Scientist 3 - Nucleic Acids Payload Engineering
Genentech - San Diego, US
Read the full job description and apply⤵️
jobrxiv.org/job/scientis...
#ScienceJobs
Genentech - San Diego, US
Read the full job description and apply⤵️
jobrxiv.org/job/scientis...
#ScienceJobs
November 7, 2026 at 4:31 PM
Scientist 3 - Nucleic Acids Payload Engineering
Genentech - San Diego, US
Read the full job description and apply⤵️
jobrxiv.org/job/scientis...
#ScienceJobs
Genentech - San Diego, US
Read the full job description and apply⤵️
jobrxiv.org/job/scientis...
#ScienceJobs
Principal Scientist – Translational Medicine (Tumor Microenvironment)
Genentech - South San Francisco, US
Read the full job description and apply⤵️
jobrxiv.org/job/principa...
#ScienceJobs
Genentech - South San Francisco, US
Read the full job description and apply⤵️
jobrxiv.org/job/principa...
#ScienceJobs
November 7, 2026 at 4:31 PM
Principal Scientist – Translational Medicine (Tumor Microenvironment)
Genentech - South San Francisco, US
Read the full job description and apply⤵️
jobrxiv.org/job/principa...
#ScienceJobs
Genentech - South San Francisco, US
Read the full job description and apply⤵️
jobrxiv.org/job/principa...
#ScienceJobs
Thank you to our SCICOM Summit Sponsors: IF/THEN, an initiative of Lyda Hill Philanthropies, Genentech, Formlabs, @blackmagicdesign.bsky.social, and Dragonfruit. Your support helped us bring together the creators, scientists, and visionaries who are redefining how the world connects with science.
November 4, 2026 at 8:46 PM
Thank you to our SCICOM Summit Sponsors: IF/THEN, an initiative of Lyda Hill Philanthropies, Genentech, Formlabs, @blackmagicdesign.bsky.social, and Dragonfruit. Your support helped us bring together the creators, scientists, and visionaries who are redefining how the world connects with science.
Scientist 3, Cell Therapy T cell Differentiation
Genentech - South San Francisco, US
Read the full job description and apply⤵️
jobrxiv.org/job/scientis...
#ScienceJobs
Genentech - South San Francisco, US
Read the full job description and apply⤵️
jobrxiv.org/job/scientis...
#ScienceJobs
November 7, 2026 at 4:31 PM
Scientist 3, Cell Therapy T cell Differentiation
Genentech - South San Francisco, US
Read the full job description and apply⤵️
jobrxiv.org/job/scientis...
#ScienceJobs
Genentech - South San Francisco, US
Read the full job description and apply⤵️
jobrxiv.org/job/scientis...
#ScienceJobs
Roche acquiring Poseida Therapeutics for up to $1.5B tells you everything about the potential of off-the-shelf CAR-T therapy. A major milestone for a company we believe in.
poseida.com
#Biotech #CellTherapy #BluegrassAngels
poseida.com
#Biotech #CellTherapy #BluegrassAngels
Genentech: Poseida Therapeutics
Breakthrough science. One moment, one day, one person at a time.
poseida.com
November 10, 2026 at 4:56 PM
Roche acquiring Poseida Therapeutics for up to $1.5B tells you everything about the potential of off-the-shelf CAR-T therapy. A major milestone for a company we believe in.
poseida.com
#Biotech #CellTherapy #BluegrassAngels
poseida.com
#Biotech #CellTherapy #BluegrassAngels
Join QBI Nov 12–13 for the second annual AI in Biology Symposium! Hear perspectives from UCSF, Stanford, UC Berkeley, Princeton, Harvard, Genentech, and more.
Poster abstracts welcome!
Details & registration: qbi.ucsf.edu/events/ai-sy...
Poster abstracts welcome!
Details & registration: qbi.ucsf.edu/events/ai-sy...
November 5, 2026 at 7:17 PM
Join QBI Nov 12–13 for the second annual AI in Biology Symposium! Hear perspectives from UCSF, Stanford, UC Berkeley, Princeton, Harvard, Genentech, and more.
Poster abstracts welcome!
Details & registration: qbi.ucsf.edu/events/ai-sy...
Poster abstracts welcome!
Details & registration: qbi.ucsf.edu/events/ai-sy...
Genentech and Biocon Settle Perjeta® BPCIA Litigation
Genentech and Biocon Settle Perjeta® BPCIA Litigation
On October 14, 2026, Genentech voluntarily dismissed BPCIA litigation No. 2:26-cv-09585 (D.N.J.) against Biocon related to its proposed Perjeta®...
www.jdsupra.com
November 2, 2026 at 6:14 PM
Genentech and Biocon Settle Perjeta® BPCIA Litigation
Genentech and Biocon Settle Perjeta® BPCIA Litigation
Genentech and Biocon Settle Perjeta® BPCIA Litigation
On October 14, 2026, Genentech voluntarily dismissed BPCIA litigation No. 2:26-cv-09585 (D.N.J.) against Biocon related to its proposed Perjeta®...
www.jdsupra.com
November 2, 2026 at 6:14 PM
Genentech and Biocon Settle Perjeta® BPCIA Litigation
Genentech and Biocon Settle Perjeta® BPCIA Litigation
Genentech and Biocon Settle Perjeta® BPCIA Litigation
On October 14, 2026, Genentech voluntarily dismissed BPCIA litigation No. 2:26-cv-09585 (D.N.J.) against Biocon related to its proposed Perjeta®...
www.jdsupra.com
November 2, 2026 at 6:14 PM
Genentech and Biocon Settle Perjeta® BPCIA Litigation
Genentech Files First BPCIA Litigation Against Proposed Xolair® Biosimilar ADL-018
Genentech Files First BPCIA Litigation Against Proposed Xolair® Biosimilar ADL-018
On October 16, 2026, Genentech filed BPCIA Litigation No. 1:26-cv-01343 (D. Del.) against Kashiv and Amneal alleging infringement of nine patents...
www.jdsupra.com
November 2, 2026 at 7:23 PM
Genentech Files First BPCIA Litigation Against Proposed Xolair® Biosimilar ADL-018
Genentech Files First BPCIA Litigation Against Proposed Xolair® Biosimilar ADL-018
Genentech Files First BPCIA Litigation Against Proposed Xolair® Biosimilar ADL-018
On October 16, 2026, Genentech filed BPCIA Litigation No. 1:26-cv-01343 (D. Del.) against Kashiv and Amneal alleging infringement of nine patents...
www.jdsupra.com
November 2, 2026 at 7:23 PM
Genentech Files First BPCIA Litigation Against Proposed Xolair® Biosimilar ADL-018
Genentech Files First BPCIA Litigation Against Proposed Xolair® Biosimilar ADL-018
Genentech Files First BPCIA Litigation Against Proposed Xolair® Biosimilar ADL-018
On October 16, 2026, Genentech filed BPCIA Litigation No. 1:26-cv-01343 (D. Del.) against Kashiv and Amneal alleging infringement of nine patents...
www.jdsupra.com
November 2, 2026 at 7:23 PM
Genentech Files First BPCIA Litigation Against Proposed Xolair® Biosimilar ADL-018
Ohh that food allergy PSA is a Genentech ad. That actually explains everything
November 2, 2026 at 8:54 PM
Ohh that food allergy PSA is a Genentech ad. That actually explains everything
Genentech
To young Nina, her father is a hero who can do "absolutely everything under the sun," from fixing broken taps to philosophizing about the world.
View Book #Subteron #Science #AdvancedTech
To young Nina, her father is a hero who can do "absolutely everything under the sun," from fixing broken taps to philosophizing about the world.
View Book #Subteron #Science #AdvancedTech
Genentech
To young Nina, her father is a hero who can do "absolutely everything under the sun," from fixing broken taps to philosophizing about the world.
bookshop.org
November 3, 2026 at 5:45 AM
Genentech
To young Nina, her father is a hero who can do "absolutely everything under the sun," from fixing broken taps to philosophizing about the world.
View Book #Subteron #Science #AdvancedTech
To young Nina, her father is a hero who can do "absolutely everything under the sun," from fixing broken taps to philosophizing about the world.
View Book #Subteron #Science #AdvancedTech
📸 Image generated using Sora by OpenAI.
Article link: www.fda.gov/drugs/resour...
Article link: www.fda.gov/drugs/resour...
FDA approves atezolizumab in combination with chemotherapy for Stage I
On October 8, 2026, the Food and Drug Administration approved atezolizumab (Tecentriq, Genentech, Inc.) in combination with a fluoropyrimidine and oxaliplatin for the adjuvant treatment of adult and p...
www.fda.gov
November 4, 2026 at 2:47 AM
📸 Image generated using Sora by OpenAI.
Article link: www.fda.gov/drugs/resour...
Article link: www.fda.gov/drugs/resour...
The firm is shifting R&D expenses to Genentech after the pair's personalized cancer vaccine autogene cevumeran failed to improve survival in a colorectal cancer Phase II study.
Despite Trial Misses, BioNTech Keeps Focused on mRNA Cancer Therapies
Despite Trial Misses, BioNTech Keeps Focused on mRNA Cancer Therapies
ebx.sh
November 3, 2026 at 10:42 PM
The firm is shifting R&D expenses to Genentech after the pair's personalized cancer vaccine autogene cevumeran failed to improve survival in a colorectal cancer Phase II study.
A heartfelt thank you to everyone who helped make it such a wonderful success, including our National Premier Sponsor, @Genentech!
And the excitement doesn’t stop here! Save the date for October 21–23, 2027! Stay tuned for registration details. We can’t wait to do it all again!
And the excitement doesn’t stop here! Save the date for October 21–23, 2027! Stay tuned for registration details. We can’t wait to do it all again!
November 1, 2026 at 3:02 PM
A heartfelt thank you to everyone who helped make it such a wonderful success, including our National Premier Sponsor, @Genentech!
And the excitement doesn’t stop here! Save the date for October 21–23, 2027! Stay tuned for registration details. We can’t wait to do it all again!
And the excitement doesn’t stop here! Save the date for October 21–23, 2027! Stay tuned for registration details. We can’t wait to do it all again!